Prospective Observational Trial of IAPA
NCT04530799 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2026-04-01
Summary
A prospective multi-center observational study to assess the incidence of influenza-associated pulmonary aspergillosis (IAPA) in ICU patients and to identify host- and pathogen related risk factors for IAPA in EORTC negative ICU patients with severe influenza.
Conditions
- Influenza With Pneumonia
- Pulmonary Aspergillosis
Interventions
- OTHER
-
Identification of biomarkers for IAPA via patient sampling
Blood, BAL, microbiome
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Joost Wauters, MD, PhD · UZ Leuven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-10
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
Countries
- Belgium
- France
- Netherlands
Study Locations
More Related Trials
-
Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.
NCT05138666 ·Status: UNKNOWN ·Phase: NA
-
Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter Study
NCT03027089 ·Status: UNKNOWN
-
Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection
NCT04527614 ·Status: COMPLETED ·Phase: NA
-
Lung Bacteriobiota and Influenza Mortality
NCT04131296 ·Status: UNKNOWN
-
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
NCT04334850 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
NCT04358419 ·Status: COMPLETED
-
Steroid and Anticoagulant Therapy in covid19
NCT05021588 ·Status: COMPLETED ·Phase: NA
-
FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
NCT04453540 ·Status: UNKNOWN
-
Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting
NCT01687816 ·Status: UNKNOWN
-
Pattern and Outcomes of Chest Diseases
NCT06053528 ·Status: UNKNOWN
-
Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
NCT00307099 ·Status: TERMINATED ·Phase: PHASE3
-
Testing for COVID-19 Infection in Asymptomatic Persons
NCT04345510 ·Status: COMPLETED
-
Home Testing of Respiratory Illness
NCT04245800 ·Status: COMPLETED
-
Drug Resistance Factors In Healthcare-associated Pneumonia
NCT02736097 ·Status: COMPLETED
-
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
NCT04581135 ·Status: COMPLETED
-
Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children
NCT05613751 ·Status: RECRUITING ·Phase: NA
-
An International Observational Study of Adults With Acute Infection
NCT07069400 ·Status: RECRUITING
-
Extra-pulmonary Clinical Manifestations of Influenza Virus and Respiratory Syncitial Virus Infections
NCT03757546 ·Status: COMPLETED
-
Long-term Pulmonary Outcomes After Infection With Sars-CoV-2
NCT04401163 ·Status: COMPLETED
-
The Applicability of Different Scoring Systems and Use of Steroids in the Treatment of Hospital Acquired Pneumonia
NCT03121690 ·Status: UNKNOWN ·Phase: PHASE4
-
A COVID-19 Symptom, Exposure and Immune Response Registry
NCT04348942 ·Status: COMPLETED
-
Virus Interactions in the Respiratory Tract; a Cohort Study With Children
NCT05318235 ·Status: COMPLETED
-
A Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)
NCT03574532 ·Status: COMPLETED
-
COVID-19 Epidemic Response Study
NCT04357496 ·Status: WITHDRAWN
-
Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.
NCT05054127 ·Status: UNKNOWN